...

Su1522 OPPOSING EFFECTS OF TM6SF2 GENOTYPE ON HEPATIC AND CARDIAC OUTCOMES BASED ON CLINICAL RISK FACTORS IN THE UK BIOBANK

Sa1634 THE DIAGNOSTIC MODELS BASED ON MACHINE LEARNING FOR IDENTIFYING ADVANCED FIBROSIS AND CIRRHOSIS IN CHRONIC HEPATITIS B PATIENTS WITH CONCUEERNT ...

Su1500 META-ANALYSIS AND SYSTEMATIC REVIEW OF THE SAFETY AND EFFICACY OF A SINGLE-PASS ALBUMIN DIALYSIS, PROMETHEUS, AND MOLECULAR ADSORBENT RECYCLING ...

Su1596 HEPATIC STEATOSIS IDENTIFICATION: A COMPREHENSIVE APPROACH USING NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING IN RADIOLOGY REPORTS

Su1623 IMPACT OF SCP2 DEFICIENCY ON HEPATIC METABOLIC PROFILING IN A MURINE MODEL OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE

Sa1647 DIFFERENTIAL EXPRESSION OF HEPATIC NUCLEAR MITOCHONDRIA ASSOCIATED GENES FOLLOWING HEPATITIS C CLEARANCE AND THEIR RELATIONSHIP WITH CIRCULATING AND ...

Su1558 GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS REDUCE HEPATIC FAT CONTEXT INDEPENDENT OF THE WEIGHT LOSS IN DIABETIC PATIENTS WITH METABOLIC ...

INTRODUCTION Hepatic encephalopathy (HE) is a potentially reversible complication of liver failure that is characteristically associated with ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer death. HCC is preventable with about 70 percent of HCC attributable to modifiable risk factors. ...